ArticleEBioMedicine2026
Biological maturation drives the hepatic-to-renal switch in erythropoietin production at birth.
Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundErythropoietin (EPO) is essential for erythropoiesis, with production shifting from the foetal liver to the kidney after birth. This hepatic-to-renal transition is a hallmark of neonatal adaptation, but the relative contribution of oxygen exposure versus intrinsic developmental processes remains unclear.
methodsWe studied plasma EPO isoform profiles in 89 neonates (developmental age 29-56 weeks; chronological age 1-92 days). Isoforms were classified as hepatic-like or renal-like based on isoelectric focusing patterns. Profiles were correlated with developmental and chronological age to assess the influence of oxygen exposure versus maturation. In parallel, human induced pluripotent stem cells (hiPSCs) were differentiated into liver organoids and cultured under hypoxic or normoxic conditions. Transcriptome and EPO mRNA expression were measured throughout differentiation to evaluate developmental and oxygen-dependent regulation.
findingsNeonatal EPO profiles shifted progressively from hepatic-like to renal-like with increasing developmental age. This transition was independent of time spent in atmospheric oxygen; preterm infants retained hepatic-like profiles for weeks after birth despite continuous oxygen exposure. In cellulo, immature hepatocytes expressed EPO robustly under hypoxia, but expression declined sharply as hepatocyte maturation advanced and was absent at later stages, regardless of oxygen tension. Maintaining the immature state of hepatic cells may be critical for responsiveness to hypoxia and for EPO production.
interpretationThese findings indicate that intrinsic hepatic maturation, rather than oxygenation, governs the silencing of hepatic-derived EPO after birth. Clarifying this process could support novel therapeutic strategies aimed at reactivating foetal-like hepatic EPO production to treat anaemia, particularly in preterm infants and in conditions associated with insufficient renal EPO production, such as chronic kidney disease.
fundingThis study was mainly supported by the Région des Pays de la Loire, The French National Agency for Research (ANR), the Fonds Européen de Développement Régional Bourgogne Franche Comté, the Marie Skłodowska-Curie action, and the Fondation Génavie.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.